| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Walz Andrew Benjamin | President, DM&C | 1400 SMITH STREET, HOUSTON | /s/ Rose Z. Pierson, Attorney-in-Fact for Andrew Benjamin Walz | 05 Feb 2026 | 0002074251 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVX | Common Stock | Options Exercise | $480,684 | +4,100 | +616% | $117.24 | 4,766 | 03 Feb 2026 | Direct | F1 |
| transaction | CVX | Common Stock | Options Exercise | $864,915 | +6,900 | +145% | $125.35 | 11,666 | 03 Feb 2026 | Direct | |
| transaction | CVX | Common Stock | Options Exercise | $813,672 | +7,200 | +62% | $113.01 | 18,866 | 03 Feb 2026 | Direct | |
| transaction | CVX | Common Stock | Options Exercise | $441,480 | +4,000 | +21% | $110.37 | 22,866 | 03 Feb 2026 | Direct | |
| transaction | CVX | Common Stock | Sale | $3,919,050 | -22,200 | -97% | $176.53 | 666 | 03 Feb 2026 | Direct | F2 |
| holding | CVX | Common Stock | 8,799 | 03 Feb 2026 | By 401(k) plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -4,100 | -100% | $0.000000 | 0 | 03 Feb 2026 | Common Stock | 4,100 | $117.24 | Direct | F3 |
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -6,900 | -100% | $0.000000 | 0 | 03 Feb 2026 | Common Stock | 6,900 | $125.35 | Direct | F4 |
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -7,200 | -100% | $0.000000 | 0 | 03 Feb 2026 | Common Stock | 7,200 | $113.01 | Direct | F5 |
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -4,000 | -38% | $0.000000 | 6,600 | 03 Feb 2026 | Common Stock | 4,000 | $110.37 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | This number is adjusted to include previously rounded fractional amounts (1 share) in connection with the settlement of the restricted stock unit award previously reported by the reporting person though no acquisition occurred. |
| F2 | This transaction was executed in multiple trades priced between $176.44 and $176.65. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided. |
| F3 | Option granted 1/25/2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively. |
| F4 | Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively. |
| F5 | Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively. |
| F6 | Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively. |